Literature DB >> 17275101

Trypanosoma cruzi-triggered meningoencephalitis is a CCR1/CCR5-independent inflammatory process.

Andréa Alice Silva1, Ester Roffê, Helton Santiago, Ana Paula Marino, Karina Kroll-Palhares, Mauro Martins Teixeira, Ricardo Tostes Gazzinelli, Joseli Lannes-Vieira.   

Abstract

Encephalitis rarely occurs during acute Trypanosoma cruzi infection. However, the central nervous system (CNS) is the major site of infection reactivation in immunocompromised patients. We show that the acute T. cruzi-triggered CD8-enriched meningoencephalitis paralleled the in situ expression of CCL3/MIP-1alpha and CCL5/RANTES mRNA. The frequency of CCR5-bearing cells was increased among peripheral blood mononuclear cells (PBMC) of infected mice. Further, CCL5/RANTES-driven in vitro PBMC migration was partially abrogated by the CCR1/CCR5 antagonist Met-RANTES. However, Met-RANTES treatment of infected mice altered neither parasitism nor intensity and nature of the CNS inflammation, indicating that T. cruzi-elicited meningoencephalitis is a CCR1/CCR5 independent process.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17275101     DOI: 10.1016/j.jneuroim.2006.12.013

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  8 in total

Review 1.  CCR5 blockade for neuroinflammatory diseases--beyond control of HIV.

Authors:  Guillaume Martin-Blondel; David Brassat; Jan Bauer; Hans Lassmann; Roland S Liblau
Journal:  Nat Rev Neurol       Date:  2016-01-18       Impact factor: 42.937

2.  The Impact of HIV Coinfection on Cerebral Malaria Pathogenesis.

Authors:  Sarah Hochman; Kami Kim
Journal:  J Neuroparasitology       Date:  2012-03-02

3.  Prokineticin receptor identified by phage display is an entry receptor for Trypanosoma cruzi into mammalian cells.

Authors:  K G Khusal; R R Tonelli; E C Mattos; C O Soares; B M Di Genova; M A Juliano; U Urias; W Colli; M J M Alves
Journal:  Parasitol Res       Date:  2014-10-17       Impact factor: 2.289

4.  Preferential brain homing following intranasal administration of Trypanosoma cruzi.

Authors:  Kacey Caradonna; Mercio Pereiraperrin
Journal:  Infect Immun       Date:  2009-01-21       Impact factor: 3.441

5.  Participation of Central Muscarinic Receptors on the Nervous Form of Chagas Disease in Mice Infected via Intracerebroventricular with Colombian Trypanosoma cruzi Strain.

Authors:  Gabriela Maira Pereira de Assis; Micheline Freire Donato; Matheus Marques Milagre; Samantha Ribeiro Béla; Mayra Fernanda Ricci; Luara Augusta Batista; Maria Elena de Lima; Fabrício de Araujo Moreira; Rosa Maria Esteves Arantes; Marta de Lana
Journal:  Pathogens       Date:  2021-01-25

6.  The CCR5 antagonist maraviroc exerts limited neuroprotection without improving neurofunctional outcome in experimental pneumococcal meningitis.

Authors:  Ngoc Dung Le; Marel Steinfort; Denis Grandgirard; Aleksandra Maleska; David Leppert; Jens Kuhle; Stephen L Leib
Journal:  Sci Rep       Date:  2022-07-28       Impact factor: 4.996

7.  Genetic Polymorphism at CCL5 Is Associated With Protection in Chagas' Heart Disease: Antagonistic Participation of CCR1+ and CCR5+ Cells in Chronic Chagasic Cardiomyopathy.

Authors:  Angelica Martins Batista; Lucia Elena Alvarado-Arnez; Silvia Marinho Alves; Gloria Melo; Isabela Resende Pereira; Leonardo Alexandre de Souza Ruivo; Andrea Alice da Silva; Daniel Gibaldi; Thayse do E S Protásio da Silva; Virginia Maria Barros de Lorena; Adriene Siqueira de Melo; Ana Karine de Araújo Soares; Michelle da Silva Barros; Vláudia Maria Assis Costa; Cynthia C Cardoso; Antonio G Pacheco; Cristina Carrazzone; Wilson Oliveira; Milton Ozório Moraes; Joseli Lannes-Vieira
Journal:  Front Immunol       Date:  2018-04-11       Impact factor: 7.561

8.  CCL3/Macrophage Inflammatory Protein-1α Is Dually Involved in Parasite Persistence and Induction of a TNF- and IFNγ-Enriched Inflammatory Milieu in Trypanosoma cruzi-Induced Chronic Cardiomyopathy.

Authors:  Daniel Gibaldi; Glaucia Vilar-Pereira; Isabela Resende Pereira; Andrea Alice Silva; Leda Castaño Barrios; Isalira Peroba Ramos; Hílton Antônio Mata Dos Santos; Ricardo Gazzinelli; Joseli Lannes-Vieira
Journal:  Front Immunol       Date:  2020-03-03       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.